The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Patrick Walters COO | XIn-the-money exercise Common Stockindirect: By HCWG LLC | +24,063 | $12.00 | $289k | 90,732 | Apr 8, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Patrick Walters COO | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By HCWG LLC | -24,063 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Ming-Fu (alan) Chiang director | XIn-the-money exercise Common Stockindirect: By HCWG LLC | +117,188 | $12.00 | $1.4M | 441,876 | Apr 8, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Ming-Fu (alan) Chiang director | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By HCWG LLC | -117,188 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Thomas C Chen CEO | XIn-the-money exercise Common Stockindirect: By HCWG LLC | +79,688 | $12.00 | $956k | 300,475 | Apr 8, 2025 |
| Mar 26, 2025 | NTHI NEONC TECHNOLOGIES HOLDINGS, INC. | Thomas C Chen CEO | XIn-the-money exercise Warrant (right to buy)derivativeindirect: By HCWG | -79,688 | $0.00 | $0 | 0 | Apr 8, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Kristy D Banas Chief Human Resources Officer | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +9 | $0.00 | $0 | 9,448 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Kristy D Banas Chief Human Resources Officer | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -9 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Andrew Jay Krasner Chief Financial Officer | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +22 | $0.00 | $0 | 11,451 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Andrew Jay Krasner Chief Financial Officer | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -22 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Carl Aaron Hess Chief Executive Officer | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +96 | $0.00 | $0 | 111,709 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Carl Aaron Hess Chief Executive Officer | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -96 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +15 | $0.00 | $0 | 72,808 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Julie Jarecke Gebauer Pres.-Health, Wealth & Career | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -15 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Matthew Furman General Counsel | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +12 | $0.00 | $0 | 37,454 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Matthew Furman General Counsel | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -12 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Joseph Stephen Kurpis PAO and Controller | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +1 | $0.00 | $0 | 1,359 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Joseph Stephen Kurpis PAO and Controller | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -1 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Alexis Faber Chief Operating Officer | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +9 | $0.00 | $0 | 9,171 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Alexis Faber Chief Operating Officer | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -9 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Anne Pullum Head of Europe | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +15 | $0.00 | $0 | 19,594 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Anne Pullum Head of Europe | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -15 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Imran Ahmed Qureshi Head of North America | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +13 | $0.00 | $0 | 9,651 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Imran Ahmed Qureshi Head of North America | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -13 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Pamela Thomson-Hall Head of International | XIn-the-money exercise Ordinary Shares, nominal value $0.000304635 per share | +5 | $0.00 | $0 | 5,783 | Apr 3, 2025 |
| Apr 1, 2025 | WTW WILLIS TOWERS WATSON PLC | Pamela Thomson-Hall Head of International | XIn-the-money exercise Dividend Equivalent Rights- 2022 RSU Awardderivative | -5 | $0.00 | $0 | 0 | Apr 3, 2025 |
| Apr 1, 2025 | XPL SOLITARIO RESOURCES CORP. | John A Labate director | XIn-the-money exercise commmon | +125,000 | $0.20 | $25k | 265,000 | Apr 2, 2025 |
| Apr 1, 2025 | XPL SOLITARIO RESOURCES CORP. | John A Labate director | XIn-the-money exercise stock optionderivative | -125,000 | $0.20 | $25k | 335,000 | Apr 2, 2025 |
| Mar 31, 2025 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | Avedick Baruyr Poladian director | XIn-the-money exercise Common Stock | +9,327 | $21.30 | $199k | 83,984 | Apr 2, 2025 |
| Mar 31, 2025 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | Avedick Baruyr Poladian director | XIn-the-money exercise Warrants (Right to buy)derivative | -9,327 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | Andrew Gould director | XIn-the-money exercise Common Stock | +2,351 | $21.30 | $50k | 38,341 | Apr 2, 2025 |
| Mar 31, 2025 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | Andrew Gould director | XIn-the-money exercise Warrants (Right to buy)derivative | -2,351 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 31, 2025 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | William R Klesse director | XIn-the-money exercise Common Stock | +25,900 | $21.30 | $552k | 208,889 | Apr 2, 2025 |
| Mar 31, 2025 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | William R Klesse director | XIn-the-money exercise Warrants (Right to buy)derivative | -25,900 | $0.00 | $0 | 3,860 | Apr 2, 2025 |
| Mar 31, 2025 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | Sunil Mathew SVP & CFO | XIn-the-money exercise Common Stock | +4,491 | $21.30 | $96k | 212,095 | Apr 2, 2025 |
| Mar 31, 2025 | OXY OCCIDENTAL PETROLEUM CORP /DE/ | Sunil Mathew SVP & CFO | XIn-the-money exercise Warrants (Right to buy)derivative | -4,491 | $0.00 | $0 | 0 | Apr 2, 2025 |
| Mar 28, 2025 | PPTA PERPETUA RESOURCES CORP. | Mckinsey Margaret Lyon (See remarks (5)) | XIn-the-money exercise Common Shares | +20,000 | $2.45 | $49k | 109,154 | Apr 1, 2025 |
| Mar 28, 2025 | PPTA PERPETUA RESOURCES CORP. | Mckinsey Margaret Lyon (See remarks (5)) | XIn-the-money exercise Director and Employee Stock Option (right to buy)derivative | -20,000 | $0.00 | $0 | 0 | Apr 1, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | John A. Ballantyne Revocable Living Trust dated 08/01/2017 owner | XIn-the-money exercise Common Stock, par value $0.001 per share | +2,560,553 | $0.00 | $0 | 2,743,591 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | John A. Ballantyne Revocable Living Trust dated 08/01/2017 owner | XIn-the-money exercise Series B Common Warrantderivative | -132,036 | $0.00 | $0 | 0 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | John Ballantyne director, owner | XIn-the-money exercise Common Stock, par value $0.001 per shareindirect: John A. Ballantyne Rev Trust 08/01/2017 | +2,560,553 | $0.00 | $0 | 2,743,591 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | John Ballantyne director, owner | XIn-the-money exercise Series B Common Warrantderivativeindirect: John A. Ballantyne Rev Trust 08/01/2017 | -132,036 | $0.00 | $0 | 0 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | Luis Malave director | XIn-the-money exercise Common Stock, par value $0.001 per share | +133,532 | $0.00 | $0 | 141,541 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | Luis Malave director | XIn-the-money exercise Series B Common Warrantderivative | -6,886 | $0.00 | $0 | 0 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | Erin Catherine Carter director | XIn-the-money exercise Common Stock, par value $0.001 per share | +40,297 | $0.00 | $0 | 43,736 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | Erin Catherine Carter director | XIn-the-money exercise Series B Common Warrantderivative | -2,078 | $0.00 | $0 | 0 | Mar 31, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | Paul Goode Chief Executive Officer | XIn-the-money exercise Common Stock, par value $0.001 per share | +15,435 | $0.00 | $0 | 18,989 | Mar 28, 2025 |
| Mar 12, 2025 | GCTK GlucoTrack, Inc. | Paul Goode Chief Executive Officer | XIn-the-money exercise Series B Common Warrantderivative | +796 | $0.00 | $0 | 0 | Mar 28, 2025 |
| Mar 27, 2025 | XPL SOLITARIO RESOURCES CORP. | Christopher E Herald President and CEO | XIn-the-money exercise commmon | +225,000 | $0.20 | $45k | 2,292,000 | Mar 27, 2025 |
| Mar 27, 2025 | XPL SOLITARIO RESOURCES CORP. | Christopher E Herald President and CEO | XIn-the-money exercise stock optionderivative | -225,000 | $0.20 | $45k | 860,000 | Mar 27, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.